170 related articles for article (PubMed ID: 30834501)
1. Colon Adenocarcinoma Stage IIA-Can We Predict Relapse?
Pinto JC; Rosa I; Martins C; Marques I; da Silva JP; Fonseca R; Freire J; Pereira AD
J Gastrointest Cancer; 2020 Mar; 51(1):116-120. PubMed ID: 30834501
[TBL] [Abstract][Full Text] [Related]
2. Tumor size as a prognostic factor in patients with stage IIa colon cancer.
Santullo F; Biondi A; Cananzi FCM; Fico V; Tirelli F; Ricci R; Rizzo G; Coco C; Mattana C; D'Ugo D; Persiani R
Am J Surg; 2018 Jan; 215(1):71-77. PubMed ID: 28410630
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of microsatellite instability determined by immunohistochemical staining of MSH2 and MLH1 in sporadic T3N0M0 colon cancer.
Parc Y; Gueroult S; Mourra N; Serfaty L; Fléjou JF; Tiret E; Parc R
Gut; 2004 Mar; 53(3):371-5. PubMed ID: 14960518
[TBL] [Abstract][Full Text] [Related]
4. Improved prediction of recurrence after curative resection of colon carcinoma using tree-based risk stratification.
Radespiel-Tröger M; Hohenberger W; Reingruber B
Cancer; 2004 Mar; 100(5):958-67. PubMed ID: 14983491
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of the relationship of DNA mismatch repair with clinicopathologic features and prognosis of colon cancer].
Qin Q; Ying J; Lyu N; Guo L; Zhi W; Zhou A; Wang J
Zhonghua Zhong Liu Za Zhi; 2015 Aug; 37(8):591-6. PubMed ID: 26714599
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy increase survival and decrease recurrence in stage IIA colon cancer.
Yun HR; Kim HC; Yun SH; Lee WY
Hepatogastroenterology; 2012; 59(120):2466-71. PubMed ID: 23169179
[TBL] [Abstract][Full Text] [Related]
7. Oncotype DX testing does not affect clinical practice in stage IIa colon cancer.
Allar BG; Messaris E; Poylin VY; Schlechter BL; Cataldo TE
Med Oncol; 2022 Feb; 39(5):59. PubMed ID: 35150339
[TBL] [Abstract][Full Text] [Related]
8. Effect of Lymph Node Retrieval and Ratio on the Long-Term Survival and Recurrence of Colon Cancer.
Rao A; Dadras M; Razzak MA; Ahmad K; Vijayasekar C
J Coll Physicians Surg Pak; 2016 Jun; 26(6):467-70. PubMed ID: 27353981
[TBL] [Abstract][Full Text] [Related]
9. Lymphovascular invasion: a comprehensive appraisal in colon and rectal adenocarcinoma.
Hogan J; Chang KH; Duff G; Samaha G; Kelly N; Burton M; Burton E; Coffey JC
Dis Colon Rectum; 2015 Jun; 58(6):547-55. PubMed ID: 25944426
[TBL] [Abstract][Full Text] [Related]
10. [Correlation between mismatch-repair protein expression and clinicopathologic features in 658 colorectal cancers].
Hu XR; Xu C; Kang Y; Wang T; Zhang Y; Yang XH
Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):827-833. PubMed ID: 30423605
[No Abstract] [Full Text] [Related]
11. Locoregional recurrence and survival after curative resection of adenocarcinoma of the colon.
Read TE; Mutch MG; Chang BW; McNevin MS; Fleshman JW; Birnbaum EH; Fry RD; Caushaj PF; Kodner IJ
J Am Coll Surg; 2002 Jul; 195(1):33-40. PubMed ID: 12113543
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting local recurrence of colonic adenocarcinoma.
Harris GJ; Church JM; Senagore AJ; Lavery IC; Hull TL; Strong SA; Fazio VW
Dis Colon Rectum; 2002 Aug; 45(8):1029-34. PubMed ID: 12195186
[TBL] [Abstract][Full Text] [Related]
13. Surveillance for early stages of colon cancer: potentials for optimizing follow-up protocols.
Gilardoni E; Bernasconi DP; Poli S; Garancini M; Luperto M; Zucchini N; Bovo G; Totis M; Bugatti A; Gianotti L
World J Surg Oncol; 2015 Aug; 13():260. PubMed ID: 26311420
[TBL] [Abstract][Full Text] [Related]
14. Histologic prognostic markers in stage IIA colorectal cancer: a comparative study.
Barresi V; Reggiani Bonetti L; Ieni A; Branca G; Tuccari G
Scand J Gastroenterol; 2016 Mar; 51(3):314-20. PubMed ID: 26554618
[TBL] [Abstract][Full Text] [Related]
15. Defective Mismatch Repair Status was not Associated with DFS and OS in Stage II Colon Cancer Treated with Adjuvant Chemotherapy.
Kim JE; Hong YS; Kim HJ; Kim KP; Lee JL; Park SJ; Lim SB; Park IJ; Kim CW; Yoon YS; Yu CS; Kim JC; Hoon KJ; Kim TW
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S630-7. PubMed ID: 26271397
[TBL] [Abstract][Full Text] [Related]
16. Perineural Invasion is a Major Prognostic and Predictive Factor of Response to Adjuvant Chemotherapy in Stage I-II Colon Cancer.
Cienfuegos JA; Martínez P; Baixauli J; Beorlegui C; Rosenstone S; Sola JJ; Rodríguez J; Hernández-Lizoáin JL
Ann Surg Oncol; 2017 Apr; 24(4):1077-1084. PubMed ID: 27624582
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Molecular Detection of Lymph Node Metastases After Curative Resection of Stage II Colon Cancer: A Systematic Pooled Data Analysis.
Gill S; Haince JF; Shi Q; Pavey ES; Beaudry G; Sargent DJ; Fradet Y
Clin Colorectal Cancer; 2015 Jun; 14(2):99-105. PubMed ID: 25619805
[TBL] [Abstract][Full Text] [Related]
18. Histopathological Predictors of Recurrence in Stage III Colon Cancer: Reappraisal of Tumor Deposits and Tumor Budding Using AJCC8 Criteria.
Landau MA; Zhu B; Akwuole FN; Pai RK
Int J Surg Pathol; 2019 Apr; 27(2):147-158. PubMed ID: 29992847
[TBL] [Abstract][Full Text] [Related]
19. Identification of patients with high-risk stage II colon cancer for adjuvant therapy.
Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Landmann RG; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
Dis Colon Rectum; 2008 May; 51(5):503-7. PubMed ID: 18322753
[TBL] [Abstract][Full Text] [Related]
20. Octogenarians present with a less aggressive phenotype of colon adenocarcinoma.
Sell NM; Qwaider YZ; Goldstone RN; Stafford CE; Cauley CE; Francone TD; Ricciardi R; Bordeianou LG; Berger DL; Kunitake H
Surgery; 2020 Dec; 168(6):1138-1143. PubMed ID: 33041068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
